http://debianws.lexgopc.com/wiki143/index.php?action=history&feed=atom&title=ATC_code_L01 ATC code L01 - Revision history 2026-05-06T21:53:43Z Revision history for this page on the wiki MediaWiki 1.43.1 http://debianws.lexgopc.com/wiki143/index.php?title=ATC_code_L01&diff=5280888&oldid=prev imported>Josvebot: v2.05b - Fix errors for CW project (Unicode control characters) 2025-12-28T16:40:15Z <p>v2.05b - Fix errors for <a href="/wiki143/index.php?title=WP:WCW&amp;action=edit&amp;redlink=1" class="new" title="WP:WCW (page does not exist)">CW project</a> (Unicode control characters)</p> <a href="http://debianws.lexgopc.com/wiki143/index.php?title=ATC_code_L01&amp;diff=5280888&amp;oldid=513109">Show changes</a> imported>Josvebot http://debianws.lexgopc.com/wiki143/index.php?title=ATC_code_L01&diff=513109&oldid=prev imported>Whywhenwhohow: 2025 changes 2024-12-23T04:36:28Z <p>2025 changes</p> <p><b>New page</b></p><div>{{Short description|Pharmaceutical drug classification}}<br /> {{ATC codes lead|L|01|Antineoplastic agents|vet=add}}<br /> <br /> =={{anchor|L01A}}L01A Alkylating agents==<br /> <br /> ==={{anchor|L01AA}}L01AA Nitrogen mustard analogues===<br /> :L01AA01 [[Cyclophosphamide]]<br /> :L01AA02 [[Chlorambucil]]<br /> :L01AA03 [[Melphalan]]<br /> :L01AA05 [[Chlormethine]]<br /> :L01AA06 [[Ifosfamide]]<br /> :L01AA07 [[Trofosfamide]]<br /> :L01AA08 [[Prednimustine]]<br /> :L01AA09 [[Bendamustine]]<br /> :L01AA10 [[Melphalan flufenamide]]<br /> <br /> ==={{anchor|L01AB}}L01AB Alkyl sulfonates===<br /> :L01AB01 [[Busulfan]]<br /> :L01AB02 [[Treosulfan]]<br /> :L01AB03 [[Mannosulfan]]<br /> <br /> ==={{anchor|L01AC}}L01AC Ethylene imines===<br /> :L01AC01 [[Thiotepa]]<br /> :L01AC02 [[Triaziquone]]<br /> :L01AC03 [[Carboquone]]<br /> <br /> ==={{anchor|L01AD}}L01AD Nitrosoureas===<br /> :L01AD01 [[Carmustine]]<br /> :L01AD02 [[Lomustine]]<br /> :L01AD03 [[Semustine]]<br /> :L01AD04 [[Streptozocin]]<br /> :L01AD05 [[Fotemustine]]<br /> :L01AD06 [[Nimustine]]<br /> :L01AD07 [[Ranimustine]]<br /> :L01AD08 [[Uramustine]]<br /> <br /> ==={{anchor|L01AG}}L01AG Epoxides===<br /> :L01AG01 [[Etoglucid]]<br /> <br /> ==={{anchor|L01AX}}L01AX Other alkylating agents===<br /> :L01AX01 [[Mitobronitol]]<br /> :L01AX02 [[Pipobroman]]<br /> :L01AX03 [[Temozolomide]]<br /> :L01AX04 [[Dacarbazine]]<br /> <br /> =={{anchor|L01B}}L01B Antimetabolites==<br /> <br /> ==={{anchor|L01BA}}L01BA Folic acid analogues===<br /> :L01BA01 [[Methotrexate]]<br /> :L01BA03 [[Raltitrexed]]<br /> :L01BA04 [[Pemetrexed]]<br /> :L01BA05 [[Pralatrexate]]<br /> <br /> ==={{anchor|L01BB}}L01BB Purine analogues===<br /> :L01BB02 [[Mercaptopurine]]<br /> :L01BB03 [[Tioguanine]]<br /> :L01BB04 [[Cladribine]]<br /> :L01BB05 [[Fludarabine]]<br /> :L01BB06 [[Clofarabine]]<br /> :L01BB07 [[Nelarabine]]<br /> :QL01BB90 [[Rabacfosadine]]<br /> <br /> ==={{anchor|L01BC}}L01BC Pyrimidine analogues===<br /> :L01BC01 [[Cytarabine]]<br /> :L01BC02 [[Fluorouracil]]<br /> :L01BC03 [[Tegafur]]<br /> :L01BC04 [[Carmofur]]<br /> :L01BC05 [[Gemcitabine]]<br /> :L01BC06 [[Capecitabine]]<br /> :L01BC07 [[Azacitidine]]<br /> :L01BC08 [[Decitabine]]<br /> :L01BC09 [[Floxuridine]]<br /> :L01BC52 Fluorouracil, combinations<br /> :L01BC53 Tegafur, combinations<br /> :L01BC58 Decitabine, combinations<br /> :L01BC59 [[Trifluridine]], combinations<br /> <br /> =={{anchor|L01C}}L01C Plant alkaloids and other natural products==<br /> <br /> ==={{anchor|L01CA}}L01CA Vinca alkaloids and analogues===<br /> :L01CA01 [[Vinblastine]]<br /> :L01CA02 [[Vincristine]]<br /> :L01CA03 [[Vindesine]]<br /> :L01CA04 [[Vinorelbine]]<br /> :L01CA05 [[Vinflunine]]<br /> :L01CA06 [[Vintafolide]]<br /> <br /> ==={{anchor|L01CB}}L01CB Podophyllotoxin derivatives===<br /> :L01CB01 [[Etoposide]]<br /> :L01CB02 [[Teniposide]]<br /> <br /> ==={{anchor|L01CC}}L01CC Colchicine derivatives===<br /> :L01CC01 [[Demecolcine]]<br /> <br /> ==={{anchor|L01CD}}L01CD Taxanes===<br /> :L01CD01 [[Paclitaxel]]<br /> :L01CD02 [[Docetaxel]]<br /> :L01CD03 [[Paclitaxel poliglumex]]<br /> :L01CD04 [[Cabazitaxel]]<br /> :L01CD51 Paclitaxel and [[encequidar]]<br /> <br /> ==={{anchor|L01CE}}L01CE Topoisomerase 1 (TOP1) inhibitors===<br /> :L01CE01 [[Topotecan]]<br /> :L01CE02 [[Irinotecan]]<br /> :L01CE03 [[Etirinotecan pegol]]<br /> :L01CE04 [[Belotecan]]<br /> <br /> ==={{anchor|L01CX}}L01CX Other plant alkaloids and natural products===<br /> :L01CX01 [[Trabectedin]]<br /> <br /> =={{anchor|L01D}}L01D Cytotoxic antibiotics and related substances==<br /> <br /> ==={{anchor|L01DA}}L01DA Actinomycines===<br /> :L01DA01 [[Dactinomycin]]<br /> <br /> ==={{anchor|L01DB}}L01DB Anthracyclines and related substances===<br /> :L01DB01 [[Doxorubicin]]<br /> :L01DB02 [[Daunorubicin]]<br /> :L01DB03 [[Epirubicin]]<br /> :L01DB04 [[Aclarubicin]]<br /> :L01DB05 [[Zorubicin]]<br /> :L01DB06 [[Idarubicin]]<br /> :L01DB07 [[Mitoxantrone]]<br /> :L01DB08 [[Pirarubicin]]<br /> :L01DB09 [[Valrubicin]]<br /> :L01DB10 [[Amrubicin]]<br /> :L01DB11 [[Pixantrone]]<br /> <br /> ==={{anchor|L01DC}}L01DC Other cytotoxic antibiotics===<br /> :L01DC01 [[Bleomycin]]<br /> :L01DC02 [[Plicamycin]]<br /> :L01DC03 [[Mitomycin]]<br /> :L01DC04 [[Ixabepilone]]<br /> :L01DC05 [[Utidelone]]<br /> <br /> =={{anchor|L01E}}L01E Protein kinase inhibitors==<br /> <br /> ==={{anchor|L01EA}}L01EA BCR-ABL tyrosine kinase inhibitors===<br /> :L01EA01 [[Imatinib]]<br /> :L01EA02 [[Dasatinib]]<br /> :L01EA03 [[Nilotinib]]<br /> :L01EA04 [[Bosutinib]]<br /> :L01EA05 [[Ponatinib]]<br /> :L01EA06 [[Asciminib]]<br /> <br /> ==={{anchor|L01EB}}L01EB Epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors===<br /> :L01EB01 [[Gefitinib]]<br /> :L01EB02 [[Erlotinib]]<br /> :L01EB03 [[Afatinib]]<br /> :L01EB04 [[Osimertinib]]<br /> :L01EB05 [[Rociletinib]]<br /> :L01EB06 [[Olmutinib]]<br /> :L01EB07 [[Dacomitinib]]<br /> :L01EB08 [[Icotinib]]<br /> :L01EB09 [[Lazertinib]]<br /> :L01EB10 [[Mobocertinib]]<br /> :L01EB11 [[Aumolertinib]]<br /> <br /> ==={{anchor|L01EC}}L01EC B-Raf serine-threonine kinase (BRAF) inhibitors===<br /> :L01EC01 [[Vemurafenib]]<br /> :L01EC02 [[Dabrafenib]]<br /> :L01EC03 [[Encorafenib]]<br /> <br /> ==={{anchor|L01ED}}L01ED Anaplastic lymphoma kinase (ALK) inhibitors===<br /> :L01ED01 [[Crizotinib]]<br /> :L01ED02 [[Ceritinib]]<br /> :L01ED03 [[Alectinib]]<br /> :L01ED04 [[Brigatinib]]<br /> :L01ED05 [[Lorlatinib]]<br /> <br /> ==={{anchor|L01EE}}L01EE Mitogen-activated protein kinase (MEK) inhibitors===<br /> :L01EE01 [[Trametinib]]<br /> :L01EE02 [[Cobimetinib]]<br /> :L01EE03 [[Binimetinib]]<br /> :L01EE04 [[Selumetinib]]<br /> :L01EE05 [[Mirdametinib]]<br /> <br /> ==={{anchor|L01EF}}L01EF Cyclin-dependent kinase (CDK) inhibitors===<br /> :L01EF01 [[Palbociclib]]<br /> :L01EF02 [[Ribociclib]]<br /> :L01EF03 [[Abemaciclib]]<br /> <br /> ==={{anchor|L01EG}}L01EG Mammalian target of rapamycin (mTOR) kinase inhibitors===<br /> :L01EG01 [[Temsirolimus]]<br /> :L01EG02 [[Everolimus]]<br /> :L01EG03 [[Ridaforolimus]]<br /> :L01EG04 [[Sirolimus]]<br /> <br /> ==={{anchor|L01EH}}L01EH Human epidermal growth factor receptor 2 (HER2) tyrosine kinase inhibitors===<br /> :L01EH01 [[Lapatinib]]<br /> :L01EH02 [[Neratinib]]<br /> :L01EH03 [[Tucatinib]]<br /> <br /> ==={{anchor|L01EJ}}L01EJ Janus-associated kinase (JAK) inhibitors===<br /> :L01EJ01 [[Ruxolitinib]]<br /> :L01EJ02 [[Fedratinib]]<br /> :L01EJ03 [[Pacritinib]]<br /> :L01EJ04 [[Momelotinib]]<br /> <br /> ==={{anchor|L01EK}}L01EK Vascular endothelial growth factor receptor (VEGFR) tyrosine kinase inhibitors===<br /> :L01EK01 [[Axitinib]]<br /> :L01EK02 [[Cediranib]]<br /> :L01EK03 [[Tivozanib]]<br /> :L01EK04 [[Fruquintinib]]<br /> <br /> ==={{anchor|L01EL}}L01EL Bruton&#039;s tyrosine kinase (BTK) inhibitors===<br /> :L01EL01 [[Ibrutinib]]<br /> :L01EL02 [[Acalabrutinib]]<br /> :L01EL03 [[Zanubrutinib]]<br /> :L01EL04 [[Orelabrutinib]]<br /> :L01EL05 [[Pirtobrutinib]]<br /> :L01EL06 [[Tirabrutinib]]<br /> <br /> ==={{anchor|L01EM}}L01EM Phosphatidylinositol-3-kinase (Pi3K) inhibitors===<br /> :L01EM01 [[Idelalisib]]<br /> :L01EM02 [[Copanlisib]]<br /> :L01EM03 [[Alpelisib]]<br /> :L01EM04 [[Duvelisib]]<br /> :L01EM05 [[Parsaclisib]]<br /> <br /> ==={{anchor|L01EN}}L01EN Fibroblast growth factor receptor (FGFR) tyrosine kinase inhibitors===<br /> :L01EN01 [[Erdafitinib]]<br /> :L01EN02 [[Pemigatinib]]<br /> :L01EN03 [[Infigratinib]]<br /> :L01EN04 [[Futibatinib]]<br /> <br /> ==={{anchor|L01EX}}L01EX Other protein kinase inhibitors===<br /> :L01EX01 [[Sunitinib]]<br /> :L01EX02 [[Sorafenib]]<br /> :L01EX03 [[Pazopanib]]<br /> :L01EX04 [[Vandetanib]]<br /> :L01EX05 [[Regorafenib]]<br /> :L01EX06 [[Masitinib]]<br /> :L01EX07 [[Cabozantinib]]<br /> :L01EX08 [[Lenvatinib]]<br /> :L01EX09 [[Nintedanib]]<br /> :L01EX10 [[Midostaurin]]<br /> :L01EX11 [[Quizartinib]]<br /> :L01EX12 [[Larotrectinib]]<br /> :L01EX13 [[Gilteritinib]]<br /> :L01EX14 [[Entrectinib]]<br /> :L01EX15 [[Pexidartinib]]<br /> :L01EX17 [[Capmatinib]]<br /> :L01EX18 [[Avapritinib]]<br /> :L01EX19 [[Ripretinib]]<br /> :L01EX21 [[Tepotinib]]<br /> :L01EX22 [[Selpercatinib]]<br /> :L01EX23 [[Pralsetinib]]<br /> :L01EX24 [[Surufatinib]]<br /> :L01EX25 [[Umbralisib]]<br /> :L01EX26 [[Sitravatinib]]<br /> :L01EX27 [[Capivasertib]]<br /> :L01EX28 [[Repotrectinib]]<br /> :QL01EX90 [[Toceranib]]<br /> <br /> =={{anchor|L01F}}L01F Monoclonal antibodies and antibody drug conjugates==<br /> <br /> ==={{anchor|L01FA}}L01FA CD20 (clusters of differentiation 20) inhibitors===<br /> :L01FA01 [[Rituximab]]<br /> :L01FA02 [[Ofatumumab]]<br /> :L01FA03 [[Obinutuzumab]]<br /> <br /> ==={{anchor|L01FB}}L01FB CD22 (clusters of differentiation 22) inhibitors===<br /> :L01FB01 [[Inotuzumab ozogamicin]]<br /> :L01FB02 [[Moxetumomab pasudotox]]<br /> <br /> ==={{anchor|L01FC}}L01FC CD38 (clusters of differentiation 38) inhibitors===<br /> :L01FC01 [[Daratumumab]]<br /> :L01FC02 [[Isatuximab]]<br /> <br /> ==={{anchor|L01FD}}L01FD HER2 (human epidermal growth factor receptor 2) inhibitors===<br /> :L01FD01 [[Trastuzumab]]<br /> :L01FD02 [[Pertuzumab]]<br /> :L01FD03 [[Trastuzumab emtansine]]<br /> :L01FD04 [[Trastuzumab deruxtecan]]<br /> :L01FD05 [[Trastuzumab duocarmazine]]<br /> :L01FD06 [[Margetuximab]]<br /> :L01FD07 [[Zanidatamab]]<br /> <br /> ==={{anchor|L01FE}}L01FE EGFR (epidermal growth factor receptor) inhibitors===<br /> :L01FE01 [[Cetuximab]]<br /> :L01FE02 [[Panitumumab]]<br /> :L01FE03 [[Necitumumab]]<br /> <br /> ==={{anchor|L01FF}}L01FF PD-1/PDL-1 (programmed cell death protein 1/ death ligand 1) inhibitors===<br /> :L01FF01 [[Nivolumab]]<br /> :L01FF02 [[Pembrolizumab]]<br /> :L01FF03 [[Durvalumab]]<br /> :L01FF04 [[Avelumab]]<br /> :L01FF05 [[Atezolizumab]]<br /> :L01FF06 [[Cemiplimab]]<br /> :L01FF07 [[Dostarlimab]]<br /> :L01FF08 [[Prolgolimab]]<br /> :L01FF09 [[Tislelizumab]]<br /> :L01FF10 [[Retifanlimab]]<br /> :L01FF11 [[Sugemalimab]]<br /> :L01FF12 [[Serplulimab]]<br /> :L01FF13 [[Toripalimab]]<br /> <br /> ==={{anchor|L01FG}}L01FG VEGF/VEGFR (vascular endothelial growth factor) inhibitors===<br /> :L01FG01 [[Bevacizumab]]<br /> :L01FG02 [[Ramucirumab]]<br /> <br /> ==={{anchor|L01FX}}L01FX Other monoclonal antibodies and antibody drug conjugates===<br /> :L01FX01 [[Edrecolomab]]<br /> :L01FX02 [[Gemtuzumab ozogamicin]]<br /> :L01FX03 [[Catumaxomab]]<br /> :L01FX04 [[Ipilimumab]]<br /> :L01FX05 [[Brentuximab vedotin]]<br /> :L01FX06 [[Dinutuximab beta]]<br /> :L01FX07 [[Blinatumomab]]<br /> :L01FX08 [[Elotuzumab]]<br /> :L01FX09 [[Mogamulizumab]]<br /> :L01FX10 [[Olaratumab]]<br /> :L01FX11 [[Bermekimab]]<br /> :L01FX12 [[Tafasitamab]]<br /> :L01FX13 [[Enfortumab vedotin]]<br /> :L01FX14 [[Polatuzumab vedotin]]<br /> :L01FX15 [[Belantamab mafodotin]]<br /> :L01FX16 [[Oportuzumab monatox]]<br /> :L01FX17 [[Sacituzumab govitecan]]<br /> :L01FX18 [[Amivantamab]]<br /> :L01FX19 [[Sabatolimab]]<br /> :L01FX20 [[Tremelimumab]]<br /> :L01FX21 [[Naxitamab]]<br /> :L01FX22 [[Loncastuximab tesirine]]<br /> :L01FX23 [[Tisotumab vedotin]]<br /> :L01FX24 [[Teclistamab]]<br /> :L01FX25 [[Mosunetuzumab]]<br /> :L01FX26 [[Mirvetuximab soravtansine]]<br /> :L01FX27 [[Epcoritamab]]<br /> :L01FX28 [[Glofitamab]]<br /> :L01FX29 [[Talquetamab]]<br /> :L01FX31 [[Zolbetuximab]]<br /> :L01FX32 [[Elranatamab]]<br /> :L01FX33 [[Tarlatamab]]<br /> :L01FX34 [[Odronextamab]]<br /> :L01FX35 [[Datopotamab deruxtecan]]<br /> :L01FX36 [[Patritumab deruxtecan]]<br /> <br /> ==={{anchor|L01FY}}L01FY Combinations of monoclonal antibodies and antibody drug conjugates===<br /> :L01FY01 [[Pertuzumab/trastuzumab|Pertuzumab and trastuzumab]]<br /> :L01FY02 [[Nivolumab/relatlimab|Nivolumab and relatlimab]]<br /> :L01FY03 [[Prolgolimab]] and [[nurulimab]]<br /> <br /> =={{anchor|L01X}}L01X Other antineoplastic agents==<br /> <br /> ==={{anchor|L01XA}}L01XA Platinum compounds===<br /> :L01XA01 [[Cisplatin]]<br /> :L01XA02 [[Carboplatin]]<br /> :L01XA03 [[Oxaliplatin]]<br /> :L01XA04 [[Satraplatin]]<br /> :L01XA05 [[Polyplatillen]]<br /> <br /> ==={{anchor|L01XB}}L01XB Methylhydrazines===<br /> :L01XB01 [[Procarbazine]]<br /> <br /> ==={{anchor|L01XD}}L01XD Sensitizers used in photodynamic/radiation therapy===<br /> :L01XD01 [[Porfimer sodium]]<br /> :L01XD03 [[Methyl aminolevulinate]]<br /> :L01XD04 [[Aminolevulinic acid]]<br /> :L01XD05 [[Temoporfin]]<br /> :L01XD06 [[Efaproxiral]]<br /> :L01XD07 [[Padeliporfin]]<br /> <br /> ==={{anchor|L01XF}}L01XF Retinoids for cancer treatment===<br /> :L01XF01 [[Tretinoin]]<br /> :L01XF02 [[Alitretinoin]]<br /> :L01XF03 [[Bexarotene]]<br /> <br /> ==={{anchor|L01XG}}L01XG Proteasome inhibitors===<br /> :L01XG01 [[Bortezomib]]<br /> :L01XG02 [[Carfilzomib]]<br /> :L01XG03 [[Ixazomib]]<br /> <br /> ==={{anchor|L01XH}}L01XH Histone deacetylase (HDAC) inhibitors===<br /> :L01XH01 [[Vorinostat]]<br /> :L01XH02 [[Romidepsin]]<br /> :L01XH03 [[Panobinostat]]<br /> :L01XH04 [[Belinostat]]<br /> :L01XH05 [[Entinostat]]<br /> :L01XH06 [[Tucidinostat]]<br /> :L01XH07 [[Resminostat]]<br /> <br /> ==={{anchor|L01XJ}}L01XJ Hedgehog pathway inhibitors===<br /> :L01XJ01 [[Vismodegib]]<br /> :L01XJ02 [[Sonidegib]]<br /> :L01XJ03 [[Glasdegib]]<br /> <br /> ==={{anchor|L01XK}}L01XK Poly (ADP-ribose) polymerase (PARP) inhibitors ===<br /> :L01XK01 [[Olaparib]]<br /> :L01XK02 [[Niraparib]]<br /> :L01XK03 [[Rucaparib]]<br /> :L01XK04 [[Talazoparib]]<br /> :L01XK05 [[Veliparib]]<br /> :L01XK06 [[Pamiparib]]<br /> :L01XK52 Niraparib and [[abiraterone]]<br /> <br /> ==={{anchor|L01XL}}L01XL Antineoplastic cell and gene therapy ===<br /> :L01XL01 [[Sitimagene ceradenovec]]<br /> :L01XL02 [[Talimogene laherparepvec]]<br /> :L01XL03 [[Axicabtagene ciloleucel]]<br /> :L01XL04 [[Tisagenlecleucel]]<br /> :L01XL05 [[Ciltacabtagene autoleucel]]<br /> :L01XL06 [[Brexucabtagene autoleucel]]<br /> :L01XL07 [[Idecabtagene vicleucel]]<br /> :L01XL08 [[Lisocabtagene maraleucel]]<br /> :L01XL09 [[Tabelecleucel]]<br /> :L01XL10 [[Nadofaragene firadenovec]]<br /> :L01XL11 [[Lifileucel]]<br /> :L01XL12 [[Obecabtagene autoleucel]]<br /> <br /> ==={{anchor|L01XM}}L01XM Isocitrate dehydrogenase (IDH) inhibitors===<br /> :L01XM01 [[Enasidenib]]<br /> :L01XM02 [[Ivosidenib]]<br /> :L01XM03 [[Olutasidenib]]<br /> :L01XM04 [[Vorasidenib]]<br /> <br /> ==={{anchor|L01XU}}L01XU Other antineoplastic agents (cont.)===<br /> :&#039;&#039;Empty group&#039;&#039;<br /> <br /> ==={{anchor|L01XX}}L01XX Other antineoplastic agents===<br /> :L01XX01 [[Amsacrine]]<br /> :L01XX02 [[Asparaginase]]<br /> :L01XX03 [[Altretamine]]<br /> :L01XX05 [[Hydroxycarbamide]]<br /> :L01XX07 [[Lonidamine]]<br /> :L01XX08 [[Pentostatin]]<br /> :L01XX10 [[Masoprocol]]<br /> :L01XX11 [[Estramustine]]<br /> :L01XX16 [[Mitoguazone]]<br /> :L01XX18 [[Tiazofurine]]<br /> :L01XX23 [[Mitotane]]<br /> :L01XX24 [[Pegaspargase]]<br /> :L01XX27 [[Arsenic trioxide]]<br /> :L01XX29 [[Denileukin diftitox]]<br /> :L01XX33 [[Celecoxib]]<br /> :L01XX35 [[Anagrelide]]<br /> :L01XX36 [[Oblimersen]]<br /> :L01XX40 [[Omacetaxine mepesuccinate]]<br /> :L01XX41 [[Eribulin]]<br /> :L01XX44 [[Aflibercept]]<br /> :L01XX46 [[Olaparib]]<br /> :L01XX52 [[Venetoclax]]<br /> :L01XX53 [[Vosaroxin]]<br /> :L01XX57 [[Plitidepsin]]<br /> :L01XX58 [[Epacadostat]]<br /> :L01XX66 [[Selinexor]]<br /> :L01XX67 [[Tagraxofusp]]<br /> :L01XX69 [[Lurbinectedin]]<br /> :L01XX72 [[Tazemetostat]]<br /> :L01XX73 [[Sotorasib]]<br /> :L01XX74 [[Belzutifan]]<br /> :L01XX75 [[Tebentafusp]]<br /> :L01XX77 [[Adagrasib]]<br /> :L01XX78 [[Navitoclax]]<br /> :L01XX79 [[Eflornithine]]<br /> :L01XX80 [[Imetelstat]]<br /> :L01XX81 [[Nirogacestat]]<br /> :L01XX82 [[Darinaparsin]]<br /> :L01XX83 [[Para-toluenesulfonamide ]]<br /> :L01XX84 [[Pelabresib]]<br /> :L01XX85 [[Idroxioleic acid]]<br /> :L01XX86 [[Calaspargase pegol]]<br /> :QL01XX91 [[Tigilanol tiglate]]<br /> :QL01XX92 [[Verdinexor]]<br /> <br /> ==={{anchor|L01XY}}L01XY Combinations of antineoplastic agents===<br /> :L01XY01 [[Cytarabine/daunorubicin|Cytarabine and daunorubicin]]<br /> :L01XY04 Bifikafusp alfa and onfekafusp alfa<br /> <br /> ==References==<br /> {{Reflist}}<br /> <br /> {{Intracellular chemotherapeutic agents}}<br /> {{Extracellular chemotherapeutic agents}}<br /> <br /> [[Category:ATC codes|L01]]<br /> [[Category:Antineoplastic drugs| ]]</div> imported>Whywhenwhohow